Top

Published in:

23-10-2024 | Dyslipidemia | Review

Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?

Authors: Maya Rashad, Lauren Williams, Don P. Wilson

Published in: Current Atherosclerosis Reports | Issue 11/2024

Abstract

Purposeof Review

A heart-healthy lifestyle adopted during childhood and sustained throughout life can reduce cardiovascular disease risk in youth with dyslipidemia. In this review, we discuss nutrition recommendations for youth (< 18 years-of-age) with dyslipidemia, compare recommendations for youth versus those for adults, review published data regarding nutrition management in the pediatric population, and discuss strategies for successful implementation in a clinical setting.

Recent Findings

Recent publications highlight the characteristics of genetic and acquired hypertriglyceridemia disorders, dietary adjuncts used for lipid-lowering, and the effectiveness of a multi-disciplinary team approach.

Summary

Nutrition interventions remain a cornerstone of lipid management and cardiovascular disease risk reduction in youth with dyslipidemia. Nutrition counseling should include age and developmentally appropriate education while also addressing barriers to implementing a heart-healthy lifestyle. A registered dietitian nutritionist plays an important role within a multidisciplinary clinic setting by providing dietary recommendations to address the needs of youth with dyslipidemia.

US Leading Causes of Death. In: National Center for Health Statistics. Centers for Disease Control and Prevention. 2024. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm. Accessed 5 May 2024.

Henson S. Testing Recommended: High Cholesterol Can Occur in Childhood. Cincinnati Children’s Blog. 2022. https://blog.cincinnatichildrens.org/healthy-living/fitness-and-nutrition/testing-recommended-high-cholesterol-can-occur-in-childhood/. Accessed 5 May 2024.

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. 2011;128(5):e1311-e1319. https://doi.org/10.1542/peds.2009-2107C.

Williams L, Baker-Smith CM, Bolick J, Carter J, Kirkpatrick C, et al. Nutrition interventions for youth with dyslipidemia an national lipid association clinical perspective. J Clin Lipidol. 2022;16(6):776–96. https://doi.org/10.1016/j.jacl.2022.07.011.CrossRefPubMed

Kirkpatrick CF, Sikand G, Petersen KS, Anderson CAM, Aspry KE, et al. Nutrition interventions for adults with dyslipidemia: a clinical perspective from the national lipid association. J Clin Lipidol. 2023;17:428–51. https://doi.org/10.1016/j.jacl.2023.05.099.CrossRefPubMed

Carson JS, Lichtenstein AH, Anderson CAM, et al. Dietary cholesterol and cardiovascular risk: a science advisory from the american heart association. Circulation. 2020;141:e39–53. https://doi.org/10.1161/CIR.0000000000000743.CrossRefPubMed

U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelines for Americans, 2020–2025. December 2020. Available at DietaryGuidelines.gov.

Paquette M, Bernard S. The evolving story of multifactorial chylomicronemia syndrome. Front Cardiovasc Med. 2022;9:886266. https://doi.org/10.3389/fcvm.2022.886266.CrossRefPubMedPubMedCentral

Stierman B, Afful J, Carroll M, Chen TC, Davy O, et al. National Health and Nutrition Examination Survey 2017-March 2020 Pandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. Natl Health Stat Report. 2021. https://doi.org/10.15620/cdc:106283.

10.

Moulin P, Dufour R, Averna M, Arca M, Cefalu AB, et al. Identification and diagnosis of patients with familial chylomicronemia syndrome (FCS): expert panel recommendations and proposal of an “FCS” score. Atheroscler. 2018;275:265–72. https://doi.org/10.1016/j.atherosclerosis.2018.06.814.CrossRef

11.

Maltais M, Brisson D, Gaudet D. Non-alcoholic fatty liver in patients with chylomicronemia. J Clin Med. 2021;10(4):669. https://doi.org/10.3390/jcm10040669.CrossRefPubMedPubMedCentral

12.

Bashir B, Ho JH, Downie P, Hamilton P, Ferns G, et al. Severe hypertriglyceridaemia and chylomicronaemia syndrome – causes, clinical presentation, and therapeutic options. Metabolites. 2023;13(5):621. https://doi.org/10.3390/metabo13050621.CrossRefPubMedPubMedCentral

13.

Murphy M, Sheng X, Macdonald T. Hypertriglyceridemia and acute pancreatitis. JAMA Intern Med. 2013. https://doi.org/10.1001/2013.jamainternmed.477.CrossRefPubMedPubMedCentral

14.

Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007. https://doi.org/10.1503/cmaj.060963.CrossRefPubMedPubMedCentral

15.

Pedersen S, Langsted A, Nordestgaard B. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. 2016;176(12):1834–42. https://doi.org/10.1001/jamainternmed.2016.6875.CrossRefPubMed

16.

Fantino M, Paquette M, Blais C, Saint-Peirre N, Bourque L, et al. Both low-fat and low-carbohydrate diets reduce triglyceride concentration in subjects with multifactorial chylomicronemia syndrome: a randomized crossover study. Nutr Res Rev. 2022;101:43–52. https://doi.org/10.1016/j.nutres.2022.02.001.CrossRef

17.

Stierman B, Mishra S, Gahche JJ, Potischman N, Hales CM. Dietary supplement use in children and adolescents aged ≤19 years – united states, 2017–2018. Weekly. 2020;69(43):1557–62. https://doi.org/10.15585/mmwr.mm6943a1.CrossRef

18.

Information for Consumers on Using Dietary Supplements. U.S. Food & Drug Administration. 2022. https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplements. Accessed 8 May 2024.

19.

Naranjo MC, Millan-Linares MC, Montserrat-de la Paz S. Chapter 14 – Niacin and hyperlipidemia. In: Patel VN, editor. Molecular Nutrition: Vitamins. Academic Press; 2020.

20.

Korneva VA, Kuznetsova TY, Julius U. Modern approaches to lower lipoprotein(a) concentrations and consequences of cardiovascular diseases. Biomedicines. 2021;9(9):1271. https://doi.org/10.3390/biomedicines9091271.CrossRefPubMedPubMedCentral

21.

Habibe MN, Kellar JZ. Niacin Toxicity. In: StatPearls. 2023. https://www.ncbi.nlm.nih.gov/books/NBK559137/. Accessed 8 May 2024.

22.

Stone NJ, Robinson JG, Lichtenstein AH, Merz CNB, Blum CB, et al. 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cariol. 2014;63(25):2889–934. https://doi.org/10.1016/j.jacc.2013.11.002.CrossRef

23.

Sun J, Buys N. Effects of probiotics consumption on lowering lipids and cvd risk factors: A systematic review and meta-analysis of randomized controlled trials. Ann Med. 2015;47(6):430–40. https://doi.org/10.3109/07853890.2015.1071872.CrossRefPubMed

24.

Cho YA, Kim J. Effects of probiotics on blood lipid concentrations: A meta-analysis of randomized controlled trials. Medicine(Baltimore). 2015;94(43):e1714. https://doi.org/10.1097/MD.0000000000001714.CrossRefPubMed

25.

FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants. U.S. Food & Drug Administration. 2023. https://www.fda.gov/news-events/press-announcements/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterminfants#:~:text=Preterm%20infants%20who%20are%20administered,yeast%20contained%20in%20the%20probiotics. Accessed 8 May 2024.

26.

Zhou Y, Jiang M, Sun JY, Cheng C, Shen H, et al. The association between vitamin D levels and the 10-year risk of cardiovascular disease: A population-based study. J Cardiovasc Nurs. 2023;38(5):E178–86. https://doi.org/10.1097/JCN.0000000000000943.CrossRefPubMed

27.

Kelishadi R, Farajzadegan Z, Bahreynian M. Association between vitamin d status and lipid profile in children and adolescents: A systematic review and meta-analysis. Int J Food Sci Nutr. 2014;65(4):404–10. https://doi.org/10.3109/09637486.2014.886186.CrossRefPubMed

28.

Kitzmann KM, Dalton WT, Stanley CM, et al. lifestyle interventions for youth who are overweight: A meta-analysis review. Health Psychol. 2010;29(1):91–101. https://doi.org/10.1037/a0017437.CrossRefPubMed

29.

Jones LK, McMinn M, Kann D, Lesko M, Sturm AC, et al. Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: A RE-AIM framework analysis. Implementation Sci Commun. 2021;2:32. https://doi.org/10.1186/s43058-021-00135-8.CrossRef

30.

Capra ME, Pederiva C, Viggiano C, Fabrizi E, Banderali G, Biasucci G. Nutritional Treatment in a Cohort of Pediatric Patients with Familial Hypercholesterolaemia: Effect on Lipid Profile. Nutrients. 2022;14(14):2817. Published 2022 Jul 8. https://doi.org/10.3390/nu14142817

31.

Massini G, Capra N, Buganza R, Nyffenegger A, de Sanctis L, Guardamagna O. Mediterranean dietary treatment in hyperlipidemic children: should it be an option? Nutrients. 2022;14(7):1344. https://doi.org/10.3390/nu14071344.CrossRefPubMedPubMedCentral

Title: Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?
Authors: Maya Rashad
Lauren Williams
Don P. Wilson
Publication date: 23-10-2024
Publisher: Springer US
Keywords: Dyslipidemia
Metabolic Disease in Childhood
Nutrition
Lifestyle Modifications
Hypertriglyceridemia
Acute Pancreatitis
Pediatric Endocrinology and Diabetology
Pediatric Cardiology
Pediatric Cardiology
Circulatory Disease
Coronary Heart Disease
Arterial Occlusive Disease
Published in: Current Atherosclerosis Reports / Issue 11/2024
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-024-01236-0

Health Data Sciences and Cardiovascular Diseases in South Asia: Innovations and Challenges in Digital Health

Digital Health
Review

Health Data Sciences and Cardiovascular Disease in Africa: Needs and the Way Forward

Review

Beyond the Guidelines: Perspectives on Management of Pediatric Patients with Hypertriglyceridemia

Open Access
Hypertriglyceridemia
Review

Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?

Ticagrelor
Review

Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?

Hypertension
Review

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

Keynote webinar | Spotlight on medication adherence

Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan